Symptoms and Impaired Quality of Life After COVID-19 Hospitalization: Effect of Therapeutic Heparin in Non-ICU Patients in the Accelerating COVID-19 Therapeutic Interventions and Vaccines 4 Acute Trial: Effect on 3-Month Symptoms and Quality of Life

Yonatan Y. Greenstein, Kinsley Hubel, Joshua Froess, Stephen R. Wisniewski, Vidya Venugopal, Yu Hsuan Lai, Jeff S. Berger, Steven Y. Chang, Christos Colovos, Faraaz Shah, Lucy Z. Kornblith, Patrick R. Lawler, Manila Gaddh, Raquel Morillo Guerrero, William Nkemdirim, Renato D. Lopes, Harmony R. Reynolds, Jose Seijas Amigo, Lana Wahid, Ajani ZahraEwan C. Goligher, Ryan Zarychanski, Eric Leifer, David T. Huang, Matthew D. Neal, Judith S. Hochman, Mary Cushman, Michelle N. Gong

Research output: Contribution to journal › Article › peer-review

1 Scopus citations

Fingerprint

Dive into the research topics of 'Symptoms and Impaired Quality of Life After COVID-19 Hospitalization: Effect of Therapeutic Heparin in Non-ICU Patients in the Accelerating COVID-19 Therapeutic Interventions and Vaccines 4 Acute Trial: Effect on 3-Month Symptoms and Quality of Life'. Together they form a unique fingerprint.

Pharmacology, Toxicology and Pharmaceutical Science

Keyphrases